home  |  genzyme  |  pharmidex  |  contact

Release the value of your CNS portfolio

Two major obstacles are recognised to inhibit the successful development of CNS medicines:

1. Difficulties in getting compounds across the blood brain barrier (BBB).
2. Difficulties in successfully measuring BBB penetration and neuro-pharmacokinetics.

Cerense^SM brings together a patented CNS drug delivery technology with world-class expertise in
neuro pharmacokinetics to overcome these twin obstacles and thus release the value of your CNS portfolio.

Read cerense literature here